11 9월 GE Healthcare to present outcome-based solutions for advancement in imaging medicine at 2018 Korean Congress of Radiology
GE Healthcare to present outcome-based solutions for advancement in imaging medicine at 2018 Korean Congress of Radiology
– To launch the ‘LOGIQ E10’, a new ultrasound system that combines the next generation imaging technology (cSound™ Architecture) and digital platform
– To unveil safety-proven MRI contrast agent Clariscan newly launched in July
– New premium MRI ‘SIGNA Architect’ and ‘AIR coil’; high-resolution image acquisition and over 30 percent faster examination
Seoul, September 11, 2018 – GE Healthcare today announced it will present an array of outcome-based solutions to improve clinical performance and efficiency in hospital management during the 74th Korean Congress of Radiology (KCR 2018) to be held at COEX in Samsung-dong, Seoul from Sept. 12.
Among GE Healthcare’s radiology solutions on display is the LOGIQ E10, the high-end edition of the LOGIQ Series, a general imaging ultrasound system for multiple disciplines, including radiology, internal medicine, health screening, and orthopedics. The LOGIQ E10 integrates various digital technology and capabilities including an advanced algorithm (cSound™ Architecture) to acquire and reconstruct data faster than ever before, enabling confident diagnosis with comprehensive tools and concise workflow. Its advanced GPU hardware technology acquires and reconstructs data in a similar way to an MRI or CT system, enabling 48 times the data throughput and 10 times the processing power of previous systems. The LOGIQ E10 also features the LOGIQ Apps to activate remote clinical application, allowing radiologists to manipulate the ultrasound’s settings with a remote control on their tablet or smartphone. Another tool is the Photo Assistant App which enables users to photograph relevant anatomy and include the photos with the clinical images sent to the radiologist.
GE’s MR systems on display of SIGNA Architect 3.0T system, a state-of-the-art imaging solution that digitizes inputs from each of 128 radio frequency (RF) channels. It uses new high channel coils and the innovative AIR Technology coil suite to obtain high-resolution images and has a compressed sensing function that enables quick inspection without loss of image quality. Such functions allow a 30 percent faster examination of the head and neck, abdomen, musculoskeletal system and spine structures. The machine also features a “fast brain” function, which integrates advanced function tests, such as AIR 48-channel brain coil, compressed sensing and HyperBand, allowing diffusion-weighted imaging, vascular imaging and basic MR imaging in less than two minutes, possibly useful for emergency patients. Moreover, the MR system’s silent scan mode allows the patient to get comfortable with the MR noise.
The company also displays the Invenia ABUS (Automated 3D breast ultrasound), the only FDA-approved breast professional ultrasound device. By designing a concave probe to fit the breast shape of a woman, it improves the image quality and reduces the pain of the person undergoing the examination, leading to an increase in diagnostic accuracy and convenience. According to Radiology, a leading academic journal, mammography in combination with the ABUS can increase the probability of detecting tumor and other abnormalities in women with dense breast by an average of 27%.
The Seno Pristina, an upgraded digital mammography system optimized for detecting calcification in dense breast tissues, will also be unveiled. It features high-resolution imaging of even microcalcifications in the dense breast tissue based on GE Healthcare’s proven ASiR (adaptive statistical iterative reconstruction) low dose reconstruction technology and Digital Breast Tomosynthesis (DBT), a 3D breast imaging technology. The Pristina Serena for interventional biopsy procedures on the mammography system is now available with the dedicated add-on biopsy kit, allowing for the versatility to easily switch to a vertical or horizontal approach to patient positioning.
Besides, the Revolution Frontier CT system comes with an all-new imaging chain, while the addition of the gemstone spectral imaging pro, an upgraded version of the gemstone spectral imaging technology, an image acquisition program for GE’s premium CT equipment, enables two times faster imaging.
GE Healthcare will also showcase Clariscan, a gadolinium-based contrast agent (GBCA) for magnetic resonance imaging, which was launched in July. The macrocyclic contrast agent with proven physical in-use stability is available for a wide range of patients from infants to children to adults. It is actively used in Europe, where 914,000 cases were reached just one year after its launch.
Francis Van Parys, President & CEO of GE Healthcare Korea said, “’Innovative of Imaging: Value-based Radiology for Patients’, the theme of the 2018 Korean Congress of Radiology aligns very well with the ‘Outcome-Based Solutions’ strategy that GE Healthcare has been pursuing,” and he added “GE Healthcare remains committed to providing innovative medical imaging technology while maintaining its close partnership with the Korean Society of Radiology to improve patient outcomes.”
Meanwhile, GE Healthcare will hold two luncheon symposiums during the KCR 2018 to share research results from domestic and overseas experts. The first symposium will feature a presentation by Prof. Lee Jae-young, Dept. of Radiology, Seoul National University Hospital on the potential clinical value from using GE’s high-end ultrasound system, the LOGIQ E10, at Room 201 on the second floor of COEX on Sept. 13. On Sept. 14, Prof. Choi Byoung-wook at Severance Hospital will make a presentation on clinical experience in cardiovascular CT with contrast enhancement.
Visitors can find GE Healthcare at booth G-03, B2 Hall on 1st floor, COEX, Seoul.
# # #
About GE Healthcare:
GE Healthcare is the $19 billion healthcare business of GE (NYSE: GE). As a leading provider of medical imaging, monitoring, biomanufacturing, and cell and gene therapy technologies, GE Healthcare enables precision health in diagnostics, therapeutics and monitoring through intelligent devices, data analytics, applications and services. With over 100 years of experience in the healthcare industry and more than 50,000 employees globally, the company helps improve outcomes more efficiently for patients, healthcare providers, researchers and life sciences companies around the world. Follow us on Facebook, LinkedIn, Twitter and The Pulse for latest news, or visit our website www.gehealthcare.com for more information.